|
|
|
Insider
Information: |
Bell Leonard |
Relationship: |
Director |
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
390,670 |
|
Indirect Shares
|
403,285 |
|
|
Direct
Value |
$71,297,275 |
|
|
Indirect Value
|
$73,599,513 |
|
|
Total
Shares |
793,955 |
|
|
Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-11-04 |
4 |
AS |
$136.00 |
$5,143,377 |
D/D |
(36,649) |
404,287 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-08-08 |
4 |
S |
$137.14 |
$138,511 |
D/D |
(1,010) |
405,289 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-02-08 |
4 |
S |
$138.02 |
$1,584,442 |
D/D |
(11,474) |
746,192 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-02-29 |
4 |
S |
$138.91 |
$554,987 |
D/D |
(3,995) |
742,197 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-01-21 |
4 |
AS |
$139.79 |
$15,631,693 |
D/D |
(110,930) |
977,726 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-11-04 |
4 |
AS |
$139.90 |
$95,123 |
I/I |
(668) |
404,287 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-01-17 |
4 |
AS |
$140.14 |
$4,582,866 |
D/D |
(32,689) |
1,043,662 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-02-05 |
4 |
S |
$140.83 |
$305,702 |
D/D |
(2,136) |
757,666 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-01-22 |
4 |
AS |
$141.28 |
$1,812,397 |
D/D |
(12,817) |
977,726 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-02-04 |
4 |
S |
$143.81 |
$325,338 |
D/D |
(2,262) |
746,997 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2017-01-09 |
4 |
AS |
$144.90 |
$48,397 |
I/I |
(334) |
403,285 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2017-01-09 |
4 |
AS |
$144.93 |
$703,345 |
D/D |
(4,853) |
403,619 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2017-01-10 |
4 |
AS |
$144.99 |
$14,499 |
D/D |
(100) |
403,619 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-02-04 |
4 |
S |
$153.63 |
$1,362,698 |
D/D |
(8,870) |
963,276 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-04-28 |
4 |
AS |
$155.12 |
$587,905 |
D/D |
(3,790) |
1,032,331 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-04-29 |
4 |
AS |
$155.31 |
$10,346,256 |
D/D |
(66,210) |
1,032,331 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-02-07 |
4 |
S |
$155.55 |
$718,672 |
D/D |
(4,620) |
986,696 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-05-20 |
4 |
AS |
$155.60 |
$10,917,528 |
D/D |
(70,000) |
1,032,331 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-02-03 |
4 |
S |
$157.14 |
$458,849 |
D/D |
(2,920) |
972,146 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-08-04 |
4 |
S |
$157.88 |
$812,293 |
D/D |
(5,145) |
1,027,186 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-09-16 |
4 |
AS |
$159.87 |
$5,136,005 |
D/D |
(32,047) |
1,021,274 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-08-12 |
4 |
AS |
$159.92 |
$12,885,910 |
D/D |
(80,458) |
1,027,186 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-06-20 |
4 |
AS |
$159.96 |
$14,770,187 |
D/D |
(90,280) |
1,032,331 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-08-13 |
4 |
AS |
$161.08 |
$3,988,594 |
D/D |
(24,542) |
1,027,186 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
CEO |
|
2014-09-18 |
4 |
AS |
$161.45 |
$2,000,043 |
D/D |
(12,388) |
1,008,886 |
0 |
- |
|
283 Records found
|
|
Page 10 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|